ANTH : Insider Transactions for Anthera Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Anthera Pharmaceuticals Inc (ANTH)

$0.00 0.00 (0.00%) as of 4:30 Tue 1/2

Download

Exchange:

Nasdaq Small Cap

Security Type:

Common

Shares Out:

11,447,000

Market Cap:

N/A

Last Volume:

23,616

Avg Vol:

0

52 Week Range:

$0.000001 - $0.008

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Drug Manufacturers - Major

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-15	2023-11-14	2023-05-16	2022-05-16

Adjust Filter Settings

Records found: 221

Page 4 of 9

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2012-06-29

4

S

$0.73

$942,071

I/I

(1,283,300)

0

-

Henney Christopher S

Director

– • –

2012-06-29

4

B

$0.75

$74,930

I/I

100,000

100,000

2.1

-

Henney Christopher S

Director

– • –

2012-06-29

4

B

$0.75

$74,930

D/D

100,000

202,429

2.39

-

President and CEO

• • –

2012-06-29

4

B

$0.76

$15,200

I/I

20,000

645,125

2.58

-

Director

– • –

2012-03-22

4

S

$2.40

$3,140,131

I/I

(1,306,700)

1,283,300

-

Director

– • –

2012-03-21

4

S

$2.87

$358,313

I/I

(125,000)

2,590,000

-

Director

– • –

2012-03-20

4

S

$2.90

$338,638

I/I

(116,800)

2,715,000

-

Chief Technology Officer

• – –

2012-03-01

4

AS

$6.57

$13,140

D/D

(2,000)

26,659

-

Kilfoil Georgina

SVP,Product Dev.& Project Mgmt

• – –

2012-02-06

4

A

$0.00

$0

D/D

5,243

24,513

-

Chief Technology Officer

• – –

2012-02-06

4

A

$0.00

$0

D/D

7,418

28,659

-

Lowe Christopher P.

C.F.O. and C.B.O.

• – –

2012-02-06

4

A

$0.00

$0

D/D

18,845

49,996

-

President and Chief Executive

• • –

2012-02-06

4

A

$0.00

$0

D/D

37,984

79,755

-

Chief Medical Officer

• – –

2012-02-06

4

A

$0.00

$0

D/D

9,923

39,519

-

Chief Medical Officer

• – –

2012-02-03

4

AS

$8.20

$246,000

D/D

(30,000)

27,967

-

Director

– • –

2012-01-28

4

OE

$4.19

$50,280

D/D

12,000

32,443

-

President and Chief Executive

• • –

2012-01-17

4

AS

$6.75

$101,250

I/I

(15,000)

627,125

-

Chief Technology Officer

• – –

2012-01-10

4

AS

$6.51

$5,205

D/D

(800)

23,241

-

Chief Technology Officer

• – –

2012-01-06

4

AS

$6.50

$7,800

D/D

(1,200)

24,441

-

Director

– • •

2011-12-30

4

S

$6.23

$155,625

I/I

(25,000)

44,969

-

10% Owner

– – •

2011-12-30

4

S

$6.23

$155,625

D/D

(25,000)

44,969

-

10% Owner

– – •

2011-12-22

4

S

$6.22

$155,605

D/D

(25,000)

45,249

-

Director

– • •

2011-12-22

4

S

$6.22

$155,605

I/I

(25,000)

45,249

-

10% Owner

– – •

2011-12-21

4

S

$6.51

$162,770

D/D

(25,000)

45,529

-

Director

– • •

2011-12-21

4

S

$6.51

$162,770

I/I

(25,000)

45,529

-

President and CEO

• • –

2011-12-15

4

AS

$6.34

$95,066

I/I

(15,000)

642,125

-

221 Records found	1 2 3 4 5 6 7 8 9	Page 4 of 9

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.